Related Experiment Video
Updated: Dec 17, 2025

06:08
Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
2.7K
Does the rs9939609 FTO gene polymorphism affect fat percentage? A meta-analysis
Maryam Gholamalizadeh1, Samaneh Mirzaei Dahka2, Farhad Vahid3
1Student Research Committee, Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Archives of Physiology and Biochemistry
|June 24, 2020
Summary
The FTO rs9939609 gene variant is linked to higher body fat percentage. Individuals carrying the A allele have increased body fat, particularly those with the TT genotype compared to AA or AT.
Area of Science:
- Genetics and Genomics
- Metabolic Health
- Obesity Research
Background:
- The fat mass and obesity-associated (FTO) gene is a key player in regulating body weight and adiposity.
- Genetic variations within the FTO gene, such as the rs9939609 polymorphism, have been implicated in obesity risk.
- Understanding the specific impact of FTO rs9939609 on body fat percentage is crucial for personalized metabolic health strategies.
Approach:
- A comprehensive meta-analysis was conducted, systematically searching major scientific databases (PubMed, Web of Science, Scopus, Embase).
- Studies investigating the association between the FTO rs9939609 polymorphism and body fat percentage (BF%) were identified and included based on predefined criteria.
- Statistical analysis was performed to synthesize the data and determine the overall effect of the polymorphism on BF%.
Key Points:
- The meta-analysis revealed a significant association between FTO rs9939609 genotypes and body fat percentage.
- Carriers of the A allele of the FTO rs9939609 polymorphism exhibited higher BF%.
- Specifically, the TT genotype was significantly associated with higher BF% compared to both AA and AT genotypes (p < 0.05).
Conclusions:
- The FTO rs9939609 polymorphism is a significant genetic determinant of body fat percentage.
- Individuals with the A allele of FTO rs9939609 are predisposed to higher body fat accumulation.
- These findings contribute to the genetic understanding of obesity and may inform future interventions targeting FTO gene variants.
More Related Videos
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
114
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
114
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
155
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
155

